Clinical Trial Detail

NCT ID NCT02272413
Title Phase III Trial BI 695502 Plus Chemotherapy vs. Avastin Plus Chemotherapy in Patients With Lung Cancer
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Paclitaxel

Bevacizumab

Age Groups: adult

No variant requirements are available.